Literature DB >> 19966511

Methylglyoxal causes dysfunction of thioredoxin and thioredoxin reductase in endothelial cells.

Ryosuke Tatsunami1, Tatsuya Oba, Kyohei Takahashi, Yoshiko Tampo.   

Abstract

Methylglyoxal (MG), a reactive dicarbonyl produced during glucose metabolism, induces oxidative stress and apoptosis. Under hyperglycemic conditions, the abnormal accumulation of MG is related to the development of diabetic complications. We examined the effects of MG on thioredoxin (Trx) and glutaredoxin (Grx) systems, two thiol-disulfide oxidoreductase systems that protect against oxidative damage of proteins, in bovine aortic endothelial cells (BAECs). The levels of protein carbonyls as markers of protein oxidation increased in BAECs exposed to MG at 5 mM, resulting in the loss of cell viability. Western blot analysis demonstrated that Trx protein level decreased when BAECs were exposed to 5 mM MG. MG also inactivated Trx reductase, which maintains Trx in the reduced/active state. Moreover, peroxiredoxin, which is dependent on Trx and Trx reductase to maintain its reduced state, was oxidized by 5 mM MG. No significant difference in the levels of Trx, Trx reductase, or peroxiredoxin was observed in BAECs exposed to MG at 1 mM; this concentration had little effect on protein carbonyl formation and cell viability. MG failed to decrease Grx activity, indicating that Trx is more susceptible to MG than Grx. Taken together, these findings suggest that MG causes dysfunction of the Trx system, including Trx and Trx reductase, in BAECs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966511     DOI: 10.1254/jphs.09131fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  8 in total

1.  Methylglyoxal-induced AMPK activation leads to autophagic degradation of thioredoxin 1 and glyoxalase 2 in HT22 nerve cells.

Authors:  Alcir Luiz Dafre; Ariana Ern Schmitz; Pamela Maher
Journal:  Free Radic Biol Med       Date:  2017-03-29       Impact factor: 7.376

2.  Methylglyoxal-Induced Protection Response and Toxicity: Role of Glutathione Reductase and Thioredoxin Systems.

Authors:  Ariana Ern Schmitz; Luiz Felipe de Souza; Barbara Dos Santos; Pamela Maher; Fernanda Martins Lopes; Giovana Ferreira Londero; Fabio Klamt; Alcir Luiz Dafre
Journal:  Neurotox Res       Date:  2017-05-06       Impact factor: 3.911

Review 3.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

4.  Methylglyoxal, the foe and friend of glyoxalase and Trx/TrxR systems in HT22 nerve cells.

Authors:  A L Dafre; J Goldberg; T Wang; D A Spiegel; P Maher
Journal:  Free Radic Biol Med       Date:  2015-07-09       Impact factor: 8.101

5.  Characterization of a Thioredoxin-1 Gene from Taenia solium and Its Encoding Product.

Authors:  Lucía Jiménez; Oscar Rodríguez-Lima; Alicia Ochoa-Sánchez; Abraham Landa
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

6.  Curcumin inhibits advanced glycation end product-induced oxidative stress and inflammatory responses in endothelial cell damage via trapping methylglyoxal.

Authors:  Yan Ping Sun; Jun Fei Gu; Xiao Bin Tan; Chun Fei Wang; Xiao Bin Jia; Liang Feng; Ji Ping Liu
Journal:  Mol Med Rep       Date:  2015-12-28       Impact factor: 2.952

Review 7.  Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations.

Authors:  Cinzia Antognelli; Andrea Perrelli; Tatiana Armeni; Vincenzo Nicola Talesa; Saverio Francesco Retta
Journal:  Antioxidants (Basel)       Date:  2020-02-01

8.  Perturbation of human coronary artery endothelial cell redox state and NADPH generation by methylglyoxal.

Authors:  Philip E Morgan; Pamela J Sheahan; Michael J Davies
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.